A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes
暂无分享,去创建一个
P. Schrauwen | M. Hesselink | M. Bornstein | V. Schrauwen-Hinderling | E. Phielix | T. van de Weijer | J. Hoeks | Michael Neinast | Z. Arany | E. Tapia | M. C. Blair | Froukje Vanweert | Michael D. Neinast | Tineke van de Weijer
[1] H. Lamb,et al. The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity , 2021, International Journal of Obesity.
[2] P. Schrauwen,et al. Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes-related metabolic disturbances. , 2020, The Journal of clinical endocrinology and metabolism.
[3] J. Borén,et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance , 2020, Nature Communications.
[4] Congye Li,et al. PP2Cm overexpression alleviates MI/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice. , 2019, European journal of pharmacology.
[5] D. Wishart,et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure , 2019, Cardiovascular Diabetology.
[6] Zhaoping Li,et al. Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance , 2019, Diabetes.
[7] D. Chuang,et al. Therapeutic Effect of Targeting Branched‐Chain Amino Acid Catabolic Flux in Pressure‐Overload Induced Heart Failure , 2019, Journal of the American Heart Association.
[8] E. White,et al. Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids. , 2019, Cell metabolism.
[9] Michael Neinast,et al. Branched Chain Amino Acids in Metabolic Disease , 2018, Current Diabetes Reports.
[10] D. Chuang,et al. The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. , 2018, Cell metabolism.
[11] M. Laakso,et al. Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes , 2017, EBioMedicine.
[12] Joshua D. Rabinowitz,et al. Metabolite Spectral Accuracy on Orbitraps. , 2017, Analytical chemistry.
[13] S. Klein,et al. Alterations in 3-Hydroxyisobutyrate and FGF21 Metabolism Are Associated With Protein Ingestion–Induced Insulin Resistance , 2017, Diabetes.
[14] R. Tian,et al. Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. , 2017, Cell metabolism.
[15] Mee-Sup Yoon. The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism , 2016, Nutrients.
[16] J. Rabinowitz,et al. A branched chain amino acid metabolite drives vascular transport of fat and causes insulin resistance , 2016, Nature Medicine.
[17] K. Nair,et al. Effect of insulin sensitizer therapy on amino acids and their metabolites. , 2015, Metabolism: clinical and experimental.
[18] C. Lynch,et al. Branched-chain amino acids in metabolic signalling and insulin resistance , 2014, Nature Reviews Endocrinology.
[19] Mahim Jain,et al. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. , 2014, Molecular genetics and metabolism.
[20] D. Chuang,et al. Benzothiophene Carboxylate Derivatives as Novel Allosteric Inhibitors of Branched-chain α-Ketoacid Dehydrogenase Kinase* , 2014, The Journal of Biological Chemistry.
[21] Heather A Zimmerman,et al. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. , 2013, Molecular genetics and metabolism.
[22] F. Haj,et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. , 2013, American journal of physiology. Endocrinology and metabolism.
[23] Terho Lehtimäki,et al. Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults , 2013, Diabetes Care.
[24] Ruth C. R. Meex,et al. Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus , 2013, PloS one.
[25] A. Peters,et al. Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.
[26] J. Calviño,et al. Insulin resistance and the metabolism of branched-chain amino acids in humans , 2012, Amino Acids.
[27] M. Roden,et al. The role of mitochondria in insulin resistance and type 2 diabetes mellitus , 2012, Nature Reviews Endocrinology.
[28] S. Adams. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. , 2011, Advances in nutrition.
[29] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.
[30] Joshua D Rabinowitz,et al. Metabolomic analysis and visualization engine for LC-MS data. , 2010, Analytical chemistry.
[31] P. Schrauwen,et al. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals , 2010, Diabetologia.
[32] K. Hayashi,et al. Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. , 2010, Biochemical and biophysical research communications.
[33] Ruth C. R. Meex,et al. Restoration of Muscle Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes by Exercise Training Is Paralleled by Increased Myocellular Fat Storage and Improved Insulin Sensitivity , 2009, Diabetes.
[34] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[35] Pengxiang She,et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.
[36] Yu Li,et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[37] M. Roden,et al. The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man , 2007, Diabetes.
[38] G. Thomas,et al. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.
[39] A. Klip,et al. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport , 2006, Trends in Endocrinology & Metabolism.
[40] E. Moser,et al. 1H NMR relaxation times of skeletal muscle metabolites at 3 T , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.
[41] S. Kahn,et al. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.
[42] Robert A. Harris,et al. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain α-keto acid dehydrogenase kinase , 2001, Current opinion in clinical nutrition and metabolic care.
[43] J. Romijn,et al. The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. , 2001, The Journal of clinical endocrinology and metabolism.
[44] R. Harris,et al. A molecular model of human branched-chain amino acid metabolism. , 1998, The American journal of clinical nutrition.
[45] A. Kuznetsov,et al. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. , 1987, Biochimica et biophysica acta.
[46] M. Brosnan,et al. Valine metabolism. Gluconeogenesis from 3-hydroxyisobutyrate. , 1986, The Biochemical journal.
[47] K. Frayn,et al. Calculation of substrate oxidation rates in vivo from gaseous exchange. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[48] T. Singer,et al. Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain keto acids. , 1983, The Journal of biological chemistry.
[49] E Hultman,et al. Diet, muscle glycogen and physical performance. , 1967, Acta physiologica Scandinavica.
[50] R. Steele,et al. INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.
[51] J. B. Weir. New methods for calculating metabolic rate with special reference to protein metabolism , 1949, The Journal of physiology.
[52] J. Wildberger,et al. Proton magnetic resonance spectroscopy reveals increased hepatic lipid content after a single high-fat meal with no additional modulation by added protein. , 2015, The American journal of clinical nutrition.
[53] M. Westerterp-Plantenga,et al. Measurement of longitudinal changes in body composition during weight loss and maintenance in overweight and obese subjects using air-displacement plethysmography in comparison with the deuterium dilution technique , 2011, International Journal of Obesity.
[54] R. Harris,et al. Regulation of branched-chain alpha-keto acid dehydrogenase kinase expression in rat liver. , 2001, The Journal of nutrition.
[55] K. M. Popov,et al. Branched-chain alpha-keto acid dehydrogenase kinase. , 2000, Methods in enzymology.
[56] J. B. Weir. New methods for calculating metabolic rate with special reference to protein metabolism. 1949. , 1990, Nutrition.